ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281617; 2) Community: the network communities that were significantly associated with the response to NSC 281617; 3) Molecule: the relationships between components within communities and NSC 281617; 4) MDR: the compounds that were significantly associated with the NSC 281617.

NSC Compound Enrichment Correlation
NSC 76356 Adenine, 9-.beta.-D-arabinofuranosyl-2-chloro- (8CI) 0.0202245331784479 0.22951255
NSC 95099 Bigitalin 0.0202245331784479 0.44306072
NSC 13477 Null 0.0220039422291536 -0.21332324
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0220039422291538 0.6369133
NSC 364830 Camptothecin Derivative 0.0220039422291538 0.49091397
NSC 382386 2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- 0.0220039422291538 -0.10300831
NSC 4320 .beta.-k-Strophanthin 0.0220039422291538 0.37406906
NSC 49488 Null 0.0220039422291538 0.19198767
NSC 631691 Null 0.0220039422291538 0.20048742
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.0220039422291538 0.33155259
Total:50  Current:20    [First] [Prev] [Next] [Last]